Masimo Corporation
$178.4
▼
-0.02%
2026-04-22 10:12:13
www.masimo.com
NMS: MASI
Explore Masimo Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$9.34 B
Current Price
$178.4
52W High / Low
$179 / $125.94
Stock P/E
46.03
Book Value
$13.84
Dividend Yield
—
ROCE
23.57%
ROE
23.43%
Face Value
—
EPS
$3.88
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
2,200
Beta
1.2
Debt / Equity
77.55
Current Ratio
2.49
Quick Ratio
1.47
Forward P/E
27.02
Price / Sales
6.12
Enterprise Value
$9.71 B
EV / EBITDA
28.13
EV / Revenue
6.36
Rating
Hold
Target Price
$177
EPS Forecast (FY)
—
Pros
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
Cons
- Return on equity is on the weaker side.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | AVITA Medical, Inc. | $5 | — | $157.45 M | — | 676.75% | 799.72% | $10.29 / $3.22 | $-0.55 |
| 2. | Bruker Corporation | $41.1 | — | $6.23 B | 0.49% | 4.76% | -0.38% | $56.22 / $28.53 | $16.15 |
| 3. | Haemonetics Corporation | $61.17 | 16.14 | $2.83 B | — | 10.74% | 19.3% | $87.32 / $47.31 | $19.46 |
| 4. | Apyx Medical Corporation | $3.94 | — | $166.48 M | — | -11.69% | -76.15% | $4.5 / $0.83 | $0.35 |
| 5. | Cerus Corporation | $2.05 | — | $397.8 M | — | -7.17% | -25.66% | $2.96 / $1.15 | $0.33 |
| 6. | Inspira Technologies Oxy B.H.N. Ltd. | $0.59 | — | $21.71 M | — | -541.24% | -3.98% | $1.65 / $0.34 | $0.07 |
| 7. | Catheter Precision, Inc. | $0.97 | — | $2.63 M | — | -43.77% | -1.92% | $15.68 / $0.79 | $2.62 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 412.5 M | 371.5 M | 370.9 M | 372 M | 600.7 M | — |
| Operating Profit | 83.9 M | 83.7 M | 64.5 M | 80.7 M | -54.6 M | — |
| Net Profit | 68.3 M | -100.4 M | 51.3 M | -170.7 M | -349.6 M | — |
| EPS in Rs | 1.3 | -1.92 | 0.98 | -3.26 | -6.68 | 0.18 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.53 B | 1.4 B | 1.28 B | 2.04 B |
| Operating Profit | 312.8 M | 63.5 M | 183.8 M | 210 M |
| Net Profit | -151.5 M | -304.9 M | 81.5 M | 143.5 M |
| EPS in Rs | -2.89 | -5.82 | 1.56 | 2.74 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.7 B | 2.63 B | 3.04 B | 3.21 B |
| Total Liabilities | 977.7 M | 1.57 B | 1.68 B | 1.87 B |
| Equity | 721.2 M | 1.05 B | 1.36 B | 1.34 B |
| Current Assets | 926 M | 1.23 B | 1.23 B | 1.31 B |
| Current Liabilities | 371.6 M | 617.7 M | 563.8 M | 630 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 217.8 M | 196.4 M | 94.1 M | 29.4 M |
| Investing CF | 275.1 M | -51.2 M | -81.2 M | -1.06 B |
| Financing CF | -520.7 M | -125.6 M | -57.1 M | 520.4 M |
| Free CF | 193.1 M | 158.1 M | 32.3 M | -26.9 M |
| Capex | -24.7 M | -38.3 M | -61.8 M | -56.3 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 9.38% | -37.35% | — | — |
| Earnings Growth % | -474.11% | -43.21% | — | — |
| Profit Margin % | -21.85% | 6.39% | 7.05% | — |
| Operating Margin % | 4.55% | 14.41% | 10.32% | — |
| Gross Margin % | 56.93% | 60.02% | 52.01% | — |
| EBITDA Margin % | 7.99% | 15.6% | 17.45% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.